Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature (Q28276669)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature	scientific article

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature (English)

0 references

0 references

0 references

schizoaffective disorder

1 reference

based on heuristic

inferred from title

David C. Steffens

5

object named as

David C Steffens

0 references

author name string

Salma R I Ribeiz

1

0 references

Débora P Bassitt

2

0 references

Jony A Arrais

3

0 references

Renata Avila

4

0 references

Cássio M C Bottino

6

0 references

language of work or name

0 references

publication date

April 2010

0 references

0 references

24

0 references

4

0 references

303-17

0 references

"Cognitive dysmetria" as an integrative theory of schizophrenia: a dysfunction in cortical-subcortical-cerebellar circuitry?

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

What are the functional consequences of neurocognitive deficits in schizophrenia?

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

Postmortem studies in schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

Senile degeneration and cognitive impairment in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

Neurotransmitter Receptors in Frontal Cortex of Schizophrenics

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

Cholinesterase inhibitors: A new class of psychotropic compounds

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

Comparison of two cognitive rating scales in medically ill patients

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group.

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

Desensitization of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine

1 reference

https://api.crossref.org/works/10.2165%2F11530260-000000000-00000

21 January 2018

A double-blind, placebo controlled, cross-over trial of adjunctive donepezil for cognitive impairment in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmenting atypical antipsychotics with a cognitive enhancer (donepezil) improves regional brain activity in schizophrenia patients: a pilot double-blind placebo controlled BOLD fMRI study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased muscarinic1 receptors in the dorsolateral prefrontal cortex of subjects with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Added donepezil for stable schizophrenia: a double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Normalization of auditory physiology by cigarette smoking in schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galanthamine in Alzheimer's disease : a new alternative to tacrine?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acetylcholinesterase inhibitor donepezil in the treatment of cognitive deficit in schizophrenia. Subanalysis of the active branch from Czech extended double blind study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive dysfunctions in schizophrenia: potential benefits of cholinesterase inhibitor adjunctive therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer disease, attention, and the cholinergic system

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine treatment as an add-on to antipsychotics in patients with schizophrenia and cognitive deficits

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive effects of adjunctive 24-weeks Rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind investigation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rivastigmine on sustained attention in schizophrenia: an FMRI study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Desensitization of nicotinic receptors in the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rivastigmine augmentation in the management of chronic schizophrenia with comorbid dementia: an open-label study investigating effects on cognition, behaviour and activities of daily living

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil for negative signs in elderly patients with schizophrenia: an add-on, double-blind, crossover, placebo-controlled study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oral cholinesterase inhibitor add-on therapy for cognitive enhancement in schizophrenia: a quantitative systematic review, Part I.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of rivastigmine on cognitive function and quality of life in patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive effectiveness of olanzapine and risperidone in first-episode psychosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind placebo-controlled case study of the use of donepezil to improve cognition in a schizoaffective disorder patient: functional MRI correlates

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of postmortem studies of Alzheimer's disease-like neuropathology in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cholinergic hypothesis of Alzheimer's disease: a review of progress

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross-over study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Donepezil effects on mood in patients with schizophrenia and schizoaffective disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Invited review: Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Add-on therapy with acetylcholinesterase inhibitors for memory dysfunction in schizophrenia: a systematic quantitative review, part 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine for the treatment of cognitive impairments in people with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholinergic systems and schizophrenia: primary pathology or epiphenomena?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No effect of donepezil on neurocognition and social cognition in young persons with stable schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Repeated nicotine exposure in rats: effects on memory function, cholinergic markers and nerve growth factor.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement in smooth pursuit eye movements after cigarette smoking in schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 12-week, double-blind, placebo-controlled trial of donepezil as an adjunct to haloperidol for treating cognitive impairments in patients with chronic schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 12-week, double-blind, placebo-controlled trial of galantamine adjunctive treatment to conventional antipsychotics for the cognitive impairments in chronic schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Canadian multicenter trial assessing memory and executive functions in patients with schizophrenia spectrum disorders treated with olanzapine

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of galantamine added to clozapine on cognition of five patients with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose galantamine augmentation inferior to placebo on attention, inhibitory control and working memory performance in nonsmokers with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neural correlates of adjunctive rivastigmine treatment to antipsychotics in schizophrenia: a randomized, placebo-controlled, double-blind fMRI study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effect of donepezil augmentation for the management of comorbid schizophrenia and dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Galantamine improves cognition in schizophrenic patients stabilized on risperidone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of low-dose donepezil in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metaanalysis of randomized trials of the efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cognitive function in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20297855

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28276669&oldid=2177579520"